<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-05-04 13:05:47CTLA-4 Protein kinase inhibitor Bristol-Myers Squibb Ipilimumab Melanoma |
Add to Reading List |
| First Page | Document Content | |
|---|---|---|
Date: 2015-05-04 13:05:47CTLA-4 Protein kinase inhibitor Bristol-Myers Squibb Ipilimumab Melanoma |
Add to Reading List |
Toxicity from Checkpoint Inhibitors James Larkin FRCP PhD Disclosures